PeptideDeepDiveResearch
Peptide Research Guides, Comparisons & Evidence
Evidence-focused peptide research guides covering mechanisms, human data, legal status, comparisons and documented safety questions.
Evidence-Based Peptide Research, Organised by Question
PeptideDeepDive brings together peptide research guides, side-by-side comparisons, study summaries and safety-focused articles. Use this research hub to explore compounds such as BPC-157, TB-500, GHK-Cu, KPV, MOTS-c, CJC-1295 and Ipamorelin without relying on marketing claims alone.
New to the subject? Start with our 7 research peptides comparison or read the FDA-approved vs. research peptides explainer before moving into individual guides.
How to use this page: choose an individual peptide guide for evidence and regulatory status, a comparison for side-by-side context, a research summary for a specific study, or the safety section for documented risks and open questions.
Individual Guides
One compound, examined in fullIn-depth peptide guides covering mechanism, human evidence, regulatory status and documented safety data for one compound at a time.
BPC-157: Legal Status, Human Evidence & How It Compares
TB-500 (Thymosin Beta-4): Legal Status, Evidence & How It Compares
GHK-Cu (Copper Peptide): Evidence, Legal Status & How It Compares
KPV Peptide: Evidence, Legal Status & How It Compares
MOTS-c Peptide: Evidence, Legal Status & How It Compares
CJC-1295: Mechanism, Evidence & Regulatory Status
Ipamorelin Peptide: Evidence, Side Effects & Legal Status
Semaglutide: The FDA-Approved Exception
Comparisons
Two compounds, side by sidePeptide comparisons showing how commonly paired or confused compounds differ in mechanism, evidence, regulatory status and reported effects.
7 Research Peptides Compared: BPC-157, TB-500, GHK-Cu & More
Semax & Selank: Evidence, Legal Status & How They Compare
GLP-1 Peptide Medicines Compared: Semaglutide, Tirzepatide & More
Mechanism Side by Side
The “Wolverine Stack,” Examined
The Distinction That Actually Matters
Research Summaries
What the data actually showsSourced summaries of peptide studies, clinical-trial results and systematic reviews, with the limits of the evidence made clear.
Safety & Risk
Documented case reports and open questionsDocumented peptide safety reports, case studies, regulatory uncertainty and research gaps that remain unresolved.
